FDA AI Medical Device Guidance 2026: New Rules for Transparency and Lifecycle Management episode artwork

EPISODE · Jun 14, 2026 · 5 MIN

FDA AI Medical Device Guidance 2026: New Rules for Transparency and Lifecycle Management

from Medical Device Global Market Access

This episode breaks down the US FDA's new draft guidance on AI-enabled medical device software, released on June 6, 2026. We explore the FDA's stricter requirements for algorithm transparency, data provenance, risk management, and real-world performance monitoring. We discuss how these changes impact pre-market submissions and post-market obligations for manufacturers and highlight the critical opportunity to provide feedback before the public comment period closes on August 5, 2026. Key Questions: - What are the four key areas of change in the FDA's 2026 AI medical device guidance? - How does the new guidance change expectations for algorithm transparency and 'black box' AI? - What is data provenance and why is it now a critical part of FDA submissions? - What new AI-specific risks must manufacturers now include in their risk management files? - How will real-world performance monitoring requirements affect post-market responsibilities? - Who is impacted by this new draft guidance? - What is the deadline for submitting public comments to the FDA? - What immediate steps should regulatory and quality teams take to prepare? Sources: - https://www.bespokementis.com/news/fda-issues-2026-guidance-clarifies-ai-medical-device-compliance How Pure Global can help: Pure Global provides end-to-end regulatory consulting for MedTech and IVD companies navigating complex requirements like the FDA's new AI guidance. Our experts help you develop compliant regulatory strategies, compile robust technical dossiers, and implement effective quality management systems for AI-enabled devices. We combine local expertise with advanced AI tools to streamline global market access and ensure you meet evolving standards for algorithm transparency, data governance, and post-market surveillance. For support with your US market access strategy or global expansion, contact us at [email protected] or visit https://pureglobal.com. Explore our free AI-powered regulatory tools and global device database at https://pureglobal.ai.

Episode metadata supplied by the publisher feed · Published Jun 14, 2026

Embed this episode

NOW PLAYING

FDA AI Medical Device Guidance 2026: New Rules for Transparency and Lifecycle Management

0:00 5:09

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Device Global Market Access?

This episode is 5 minutes long.

When was this Medical Device Global Market Access episode published?

This episode was published on June 14, 2026.

Can I download this Medical Device Global Market Access episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!